<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: revascularization</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>How to quickly spot signs of stroke</title>
   	 <description>(HealthDay)—Sudden numbness or weakness in the face, arms or legs on one side of the body, confusion and trouble speaking are among the signs that someone is having a stroke.  The sooner a stroke is recognized and treated, the greater the chance of recovery, experts say.</description>
     <link>http://medicalxpress.com/news/2013-05-quickly.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 13 May 2013 18:10:01 EST</pubDate>
	 <guid isPermaLink="false">news287685901</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/howtoquickly.jpg" width="90" height="90" />
</item>
<item>
     <title>Study examines impact of minimally invasive surgery</title>
   	 <description>(HealthDay)—For specific types of surgery, minimally invasive procedures correlate with significantly lower health plan spending and fewer days of absence from work, compared with standard surgery, according to a study published online March 20 in JAMA Surgery.</description>
     <link>http://medicalxpress.com/news/2013-03-impact-minimally-invasive-surgery.html</link>
	 <category>Surgery</category>
	 <pubDate>Thu, 21 Mar 2013 15:30:01 EST</pubDate>
	 <guid isPermaLink="false">news283095583</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/2-1-studyexamine.jpg" width="90" height="90" />
</item>
<item>
     <title>ACC: Niacin/Laropiprant no benefit in vascular disease</title>
   	 <description>(HealthDay)—For patients with preexisting occlusive vascular disease, the combination of niacin and the anti-flushing agent laropiprant provides no benefit and is associated with an increase in serious side effects, according to a study presented at the annual meeting of the American College of Cardiology, held from March 9 to 11 in San Francisco.</description>
     <link>http://medicalxpress.com/news/2013-03-acc-niacinlaropiprant-benefit-vascular-disease.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 12 Mar 2013 12:50:01 EST</pubDate>
	 <guid isPermaLink="false">news282308529</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/accniacinlar.jpg" width="90" height="90" />
</item>
<item>
     <title>New anti-clotting drug more effective than current treatment</title>
   	 <description>A new and experimental anti-clotting drug, cangrelor, proved better than the commonly used clopidogrel and was significantly more effective at preventing blood clots in a large trial of patients who underwent coronary stent procedures. These data, from the phase III CHAMPION PHOENIX study, were presented at the American College of Cardiology's 62nd Annual Scientific Session and published simultaneously in the New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2013-03-anti-clotting-drug-effective-current-treatment.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 11 Mar 2013 10:21:55 EST</pubDate>
	 <guid isPermaLink="false">news282216106</guid>
	 
</item>
<item>
     <title>Study examines thinning of heart muscle wall among patients with coronary artery disease</title>
   	 <description>Among patients with coronary artery disease referred for cardiovascular magnetic resonance and found to have regional myocardial wall thinning (of the heart muscle), limited scar burden was associated with improved contraction of the heart and reversal of wall thinning after revascularization, suggesting that myocardial thinning is potentially reversible, according to a study appearing in the March 6 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2013-03-thinning-heart-muscle-wall-patients.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 05 Mar 2013 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news281710179</guid>
	 
</item>
<item>
     <title>In STEMI, diabetes linked to worse long-term outcomes</title>
   	 <description>(HealthDay)—In patients undergoing primary angioplasty for ST-segment elevation myocardial infarction (STEMI), diabetes is associated with worse long-term outcomes, including mortality, reinfarction, stent thrombosis, and target vessel revascularization (TVR), according to research published online Dec. 28 in Diabetes Care.</description>
     <link>http://medicalxpress.com/news/2013-01-stemi-diabetes-linked-worse-long-term.html</link>
	 <category>Diabetes</category>
	 <pubDate>Wed, 30 Jan 2013 10:30:02 EST</pubDate>
	 <guid isPermaLink="false">news278762991</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/instemidiabe.jpg" width="90" height="90" />
</item>
<item>
     <title>Prehospital antiplatelets improve graft intervention outcomes</title>
   	 <description>(HealthDay)—Prehospital use of antiplatelet therapy, either aspirin/clopidogrel or dual antiplatelet therapy (DAPT), is associated with a lower incidence of major adverse cardiac events after saphenous vein graft (SVG) intervention, according to research published in the Jan. 15 issue of The American Journal of Cardiology.</description>
     <link>http://medicalxpress.com/news/2013-01-prehospital-antiplatelets-graft-intervention-outcomes.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 28 Jan 2013 13:20:05 EST</pubDate>
	 <guid isPermaLink="false">news278599665</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/prehospitala.jpg" width="90" height="90" />
</item>
<item>
     <title>Increases in mean platelet volume after PCI tied to death</title>
   	 <description>(HealthDay)—For patients who undergo percutaneous coronary intervention (PCI), mortality is associated with increases in mean platelet volume (MPV) over time following the procedure, according to a study published in the Jan. 15 issue of The American Journal of Cardiology.</description>
     <link>http://medicalxpress.com/news/2013-01-platelet-volume-pci-tied-death.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 25 Jan 2013 13:50:01 EST</pubDate>
	 <guid isPermaLink="false">news278341482</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/increasesinm.jpg" width="90" height="90" />
</item>
<item>
     <title>Smoking affects heart surgery outcome even a year after quitting</title>
   	 <description>Smoking cessation even a year prior to coronary artery bypass grafting (CABG) surgery does not fully normalize the changes smoking has made to the saphenous (leg) veins used for the surgery and may lead to later graft failure, according to a study published in the January 2013 issue of The Annals of Thoracic Surgery.</description>
     <link>http://medicalxpress.com/news/2013-01-affects-heart-surgery-outcome-year.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 02 Jan 2013 11:05:57 EST</pubDate>
	 <guid isPermaLink="false">news276347134</guid>
	 
</item>
<item>
     <title>Brain angioplasty and stents found safe and effective for stroke patients</title>
   	 <description>Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online in the journal Radiology.</description>
     <link>http://medicalxpress.com/news/2012-12-brain-angioplasty-stents-safe-effective.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 11 Dec 2012 00:00:11 EST</pubDate>
	 <guid isPermaLink="false">news274382382</guid>
	 
</item>
<item>
     <title>Treating coronary heart disease in kidney failure patients</title>
   	 <description>Among the two available procedures for opening blocked arteries surrounding the heart, one appears to be safer than the other for dialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings may help lead to better care for kidney failure patients with coronary heart disease.</description>
     <link>http://medicalxpress.com/news/2012-11-coronary-heart-disease-kidney-failure.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 29 Nov 2012 17:29:29 EST</pubDate>
	 <guid isPermaLink="false">news273432560</guid>
	 
</item>
<item>
     <title>Surprise origin for coronary arteries could speed advances in regenerative medicine</title>
   	 <description>During embryonic development, the all-important coronary arteries arise from cells previously considered incapable of producing them, according to scientists at Albert Einstein College of Medicine of Yeshiva University. The research, carried out in mice and published today in the online edition of the journal Cell, may speed development of regenerative therapies for heart disease.</description>
     <link>http://medicalxpress.com/news/2012-11-coronary-arteries-advances-regenerative-medicine.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 21 Nov 2012 12:00:20 EST</pubDate>
	 <guid isPermaLink="false">news272714268</guid>
	 
</item>
<item>
     <title>Some heart patients may respond differently to anti-platelet drugs</title>
   	 <description>The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.</description>
     <link>http://medicalxpress.com/news/2012-11-heart-patients-differently-anti-platelet-drugs.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 05 Nov 2012 13:03:07 EST</pubDate>
	 <guid isPermaLink="false">news271342977</guid>
	 
</item>
<item>
     <title>Second generation drug-eluting stents are safe and effective in treatment of left main coronary artery disease</title>
   	 <description>A study found that second-generation drug-eluting stents are safe and effective in the treatment of left main coronary artery lesions. Results of the ISAR-LEFT MAIN 2 trial were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.</description>
     <link>http://medicalxpress.com/news/2012-10-drug-eluting-stents-safe-effective-treatment.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 24 Oct 2012 14:10:02 EST</pubDate>
	 <guid isPermaLink="false">news270305853</guid>
	 
</item>
<item>
     <title>Simple, inexpensive risk score can shorten length of stay for patients</title>
   	 <description>A simple-to-use risk score can identify low-risk patients following a severe heart attack (STEMI) and may provide an opportunity to employ early discharge strategies to reduce length of hospital stay and save hospital costs without compromising the safety of the patient, based on a study presented by the Minneapolis Heart Institute Foundation on Oct. 23 at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) conference.</description>
     <link>http://medicalxpress.com/news/2012-10-simple-inexpensive-score-shorten-length.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 23 Oct 2012 08:57:01 EST</pubDate>
	 <guid isPermaLink="false">news270201404</guid>
	 
</item>
<item>
     <title>Study sheds light on bone marrow stem cell therapy for pancreatic recovery</title>
   	 <description>Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that a blood vessel-building gene boosts the ability of human bone marrow stem cells to sustain pancreatic recovery in a laboratory mouse model of insulin-dependent diabetes.</description>
     <link>http://medicalxpress.com/news/2012-10-bone-marrow-stem-cell-therapy.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 02 Oct 2012 17:08:47 EST</pubDate>
	 <guid isPermaLink="false">news268416504</guid>
	 
</item>
<item>
     <title>Duration of antiplatelet drugs for drug-eluting stents studied</title>
   	 <description>(HealthDay)—In patients receiving drug-eluting stents, dual antiplatelet therapy can be safely discontinued during the first year, according to two studies published online Sept. 19 in the Journal of the American College of Cardiology.</description>
     <link>http://medicalxpress.com/news/2012-09-duration-antiplatelet-drugs-drug-eluting-stents.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 20 Sep 2012 20:30:02 EST</pubDate>
	 <guid isPermaLink="false">news267382961</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/durationofan.jpg" width="90" height="90" />
</item>
<item>
     <title>Nicotine replacement doesn't increase cardio risk after ACS</title>
   	 <description>(HealthDay)—Use of nicotine replacement therapy (NRT) does not increase the risk of adverse cardiovascular events in the first year following acute coronary syndromes (ACS), according to research published in the Oct. 1 issue of The American Journal of Cardiology.</description>
     <link>http://medicalxpress.com/news/2012-09-nicotine-doesnt-cardio-acs.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 17 Sep 2012 13:40:01 EST</pubDate>
	 <guid isPermaLink="false">news267105522</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/nicotinerepl.jpg" width="90" height="90" />
</item>
<item>
     <title>New study clarifies benefits of coronary stents</title>
   	 <description>(Medical Xpress)—Who should get stents, the tiny metal tubes designed to keep once-clogged coronary arteries open? Someone who is having a heart attack certainly should, and the life-prolonging benefits have been demonstrated in several studies. But results have been more ambiguous for patients who have &quot;stable angina&quot;: chest pain that comes with exertion but goes away at rest.</description>
     <link>http://medicalxpress.com/news/2012-09-benefits-coronary-stents.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 12 Sep 2012 09:15:24 EST</pubDate>
	 <guid isPermaLink="false">news266660103</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newstudyclar.jpg" width="90" height="90" />
</item>
<item>
     <title>Early use of stents better than medical therapy alone for certain patients</title>
   	 <description>For patients with stable coronary artery disease who have at least one narrowed blood vessel that compromises flow to the heart, medical therapy alone leads to a significantly higher risk of hospitalization and the urgent need for a coronary stent when compared with therapy that also includes initial placement of artery-opening stents.</description>
     <link>http://medicalxpress.com/news/2012-08-early-stents-medical-therapy-patients.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 28 Aug 2012 04:12:56 EST</pubDate>
	 <guid isPermaLink="false">news265345968</guid>
	 
</item>
<item>
     <title>Non-invasive fractional flow reserve in the identification of flow-restricting arterial blockage</title>
   	 <description>Data presented today from the prospective Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography (DeFACTO) study show that, when compared to standard coronary angiography (CT), the non-invasive assessment of fractional flow reserve by computed tomography (FFRct) provides a more accurate determination of which lesions require invasive evaluation.(1)</description>
     <link>http://medicalxpress.com/news/2012-08-non-invasive-fractional-reserve-identification-flow-restricting.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 27 Aug 2012 10:00:36 EST</pubDate>
	 <guid isPermaLink="false">news265280425</guid>
	 
</item>
<item>
     <title>New device to remove stroke-causing blood clots proves better than standard tool</title>
   	 <description>Stroke is the fourth leading cause of death and a common cause of long-term disability in the United States, but doctors have very few proven treatment methods. Now a new device that mechanically removes stroke-causing clots from the brain is being hailed as a game-changer.</description>
     <link>http://medicalxpress.com/news/2012-08-clot-devices-successful-tools-acute.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sun, 26 Aug 2012 11:49:15 EST</pubDate>
	 <guid isPermaLink="false">news265200531</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newdevicetor.jpg" width="90" height="90" />
</item>
<item>
     <title>Anti-clotting drugs yield similar results</title>
   	 <description>The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs – prasugrel and clopidogrel – in preventing the first occurrence of death, heart attack or stroke, according to Duke University Medical Center cardiologists.</description>
     <link>http://medicalxpress.com/news/2012-08-anti-clotting-drugs-yield-similar-results.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sun, 26 Aug 2012 04:05:08 EST</pubDate>
	 <guid isPermaLink="false">news265172673</guid>
	 
</item>
<item>
     <title>Increased stroke risk at 30-days post-CABG versus PCI</title>
   	 <description>(HealthDay) -- The risk of stroke at 30 days is significantly higher in patients who undergo coronary revascularization with coronary artery bypass graft (CABG) surgery compared to those who undergo percutaneous coronary intervention (PCI), according to research published in the Aug. 28 issue of the Journal of the American College of Cardiology.</description>
     <link>http://medicalxpress.com/news/2012-08-days-post-cabg-pci.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 21 Aug 2012 04:16:46 EST</pubDate>
	 <guid isPermaLink="false">news264741396</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/increasedstr.jpg" width="90" height="90" />
</item>
<item>
     <title>Protecting the hearts of those waiting for kidney and liver transplants</title>
   	 <description>As thousands of Americans await a life-saving kidney or liver transplant, medical teams are paying close attention to another organ: their hearts.</description>
     <link>http://medicalxpress.com/news/2012-07-hearts-kidney-liver-transplants.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 12 Jul 2012 09:51:50 EST</pubDate>
	 <guid isPermaLink="false">news261305493</guid>
	 
</item>
<item>
     <title>New platelet blocker reduces blood clots, artery-opening procedures</title>
   	 <description>A new investigational platelet blocker reduces the rate of clotted arteries and the need for artery-opening revascularization procedures in the legs in people with peripheral artery disease  (PAD), according to new research presented in the American Heart Association&amp;#146;s Emerging Science Series  webinar.</description>
     <link>http://medicalxpress.com/news/2012-06-platelet-blocker-blood-clots-artery-opening.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 21 Jun 2012 06:45:34 EST</pubDate>
	 <guid isPermaLink="false">news259479926</guid>
	 
</item>
<item>
     <title>Study examines exercise testing in asymptomatic patients after coronary revascularization</title>
   	 <description>Asymptomatic patients who undergo treadmill exercise echocardiography (ExE) after coronary revascularization may be identified as being at high risk but those patients do not appear to have more favorable outcomes with repeated revascularization, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication. The article is part of the journal's Less is More series.</description>
     <link>http://medicalxpress.com/news/2012-05-asymptomatic-patients-coronary-revascularization.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 14 May 2012 11:00:02 EST</pubDate>
	 <guid isPermaLink="false">news256208973</guid>
	 
</item>
<item>
     <title>Post-SES implantation, statins prevent late revascularization</title>
   	 <description>(HealthDay) -- For patients who undergo sirolimus-eluting stent (SES) implantation, use of statin therapy is associated with a reduced risk of late target lesion revascularization (TLR), according to a study published in the May 15 issue of The American Journal of Cardiology.</description>
     <link>http://medicalxpress.com/news/2012-05-post-ses-implantation-statins-late-revascularization.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sat, 12 May 2012 13:37:17 EST</pubDate>
	 <guid isPermaLink="false">news256048624</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/postsesimpla.jpg" width="90" height="90" />
</item>
<item>
     <title>The Cardiovascular Research Foundation announces initiation of HORIZONS-AMI II Clinical Trial</title>
   	 <description>The Cardiovascular Research Foundation (CRF) today announced the initiation of the HORIZONS-AMI II randomized trial, evaluating Promus Element platinum-chromium everolimus-eluting stents versus Omega bare-metal stents in patients with heart attack undergoing primary angioplasty with bivalirudin anticoagulation. The HORIZONS-AMI II trial will also investigate the chronic use of the antiplatelet medications prasugrel versus clopidogrel in patients free of major events at 30 days.</description>
     <link>http://medicalxpress.com/news/2012-03-cardiovascular-foundation-horizons-ami-ii-clinical.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 27 Mar 2012 09:58:18 EST</pubDate>
	 <guid isPermaLink="false">news252060971</guid>
	 
</item>
<item>
     <title>Study shows survival advantage for bypass surgery compared with non-surgical procedure</title>
   	 <description>A new comparative effectiveness study found older adults with stable coronary heart disease (CHD) who underwent bypass surgery had better long-term survival rates than those who underwent a non-surgical procedure to improve blood flow to the heart muscle, also called revascularization.</description>
     <link>http://medicalxpress.com/news/2012-03-survival-advantage-bypass-surgery-non-surgical.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 27 Mar 2012 09:55:24 EST</pubDate>
	 <guid isPermaLink="false">news252060917</guid>
	 
</item>


</channel>
</rss>
